PhytoPark Syrup: Herbal Neuroprotective Syrup in Parkinson’s disease

This research reports the formulation and extensive evaluation of PhytoPark Syrup, a new phytopharmaceutical preparation with the purpose of inducing neuroprotection and cognitive improvement. The syrup consists of thoroughly researched medicinal plants such as Mucuna pruriens, Withania somnifera, Bacopa monnieri, Curcuma longa, Ginkgo biloba, and Piper nigrum, which are all characterized by their synergistic neuroprotective, antioxidant, anti-inflammatory, and cognition-enhancing effects. The preparation is based on honey and sorbitol syrup, increasing bioavailability, hiding bitter herbal flavor, and increasing patient compliance, especially in elderly patients and patients with dysphagia. Mucuna pruriens, a natural L-DOPA source, is the major neuroactive ingredient, providing dopaminergic activity in Parkinson's disease. The product was formulated by employing judiciously optimized extraction and mixing processes for maintaining the bioactive components along with synergistic activity. Prolonged physicochemical characterization studies were performed, comprising pH, viscosity, refractive index analysis, and microbial load testing and accelerated stability studies, all of which established the quality, safety, and shelf life stability of the formulation over a period of time. Preliminary results show that PhytoPark Syrup is organoleptically acceptable, stable, and of much interest as a natural remedy for the treatment of neurodegenerative disorders and age-related cognitive impairment. By leveraging the therapeutic potential of classic botanicals in contemporary, user-friendly form, PhytoPark Syrup is a promising addition to the discipline of herbal neuropharmacology. Additional in vivo experiments and clinical trials should be conducted to confirm its efficacy and determine its marketability and regulatory approval potential.